Skip to main content

Advertisement

Log in

Cerebrospinal fluid MOG-antibodies in anti-NMDA receptor encephalitis with leptomeningeal enhancement

  • Letter to the Editor
  • Published:
Neurological Sciences Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. Jurynczyk M, Messina S, Woodhall MR, Raza N, Everett R, Roca-Fernandez A, Tackley G, Hamid S, Sheard A, Reynolds G, Chandratre S, Hemingway C, Jacob A, Vincent A, Leite MI, Waters P, Palace J (2017) Clinical presentation and prognosis in MOG-antibody disease: a UK study. Brain 140:3128–3138

    Article  Google Scholar 

  2. Ogawa R, Nakashima I, Takahashi T, Kaneko K, Akaishi T, Takai Y, Sato DK, Nishiyama S, Misu T, Kuroda H, Aoki M, Fujihara K (2017) MOG antibody-positive, benign, unilateral, cerebral cortical encephalitis with epilepsy. Neurol Neuroimmunol Neuroinflamm 4:e322

    Article  Google Scholar 

  3. Fujimori J, Takai Y, Nakashima I, Sato DK, Takahashi T, Kaneko K, Nishiyama S, Watanabe M, Tanji H, Kobayashi M, Misu T, Aoki M, Fujihara K (2017) Bilateral frontal cortex encephalitis and paraparesis in a patient with anti-MOG antibodies. J Neurol Neurosurg Psychiatry 88:534–536

    Article  Google Scholar 

  4. Nagabushana D, Shah R, Pendharkar H, Agrawal A, Kulkarni GB, Rajendran S, Alladi S, Mahadevan A (2019) MOG antibody seropositive aseptic meningitis: a new clinical phenotype. J Neuroimmunol 333:476960

    Article  CAS  Google Scholar 

  5. Yanagida A, Iizuka T, Nagai T, Usui R, Kaneko J, Akutsu T, Hanajima R, Kanazawa N, Nishiyama K (2017) MOG-IgG-positive multifocal myelitis with intrathecal IgG synthesis as a spectrum associated with MOG autoimmunity: two case reports. J Neurol Sci 382:40–43

    Article  Google Scholar 

  6. Titulaer MJ, Höftberger R, Iizuka T, Leypoldt F, McCracken L, Cellucci T, Benson LA, Shu H, Irioka T, Hirano M, Singh G, Cobo Calvo A, Kaida K, Morales PS, Wirtz PW, Yamamoto T, Reindl M, Rosenfeld MR, Graus F, Saiz A, Dalmau J (2014) Overlapping demyelinating syndromes and anti–N-methyl-D-aspartate receptor encephalitis. Ann Neurol 75:411–428

    Article  CAS  Google Scholar 

  7. Kaneko K, Sato DK, Misu T, Kurosawa K, Nakashima I, Fujihara K, Aoki M (2014) Anti-N-methyl-D-aspartate receptor encephalitis with multiphasic demyelination. Ann Neurol 76:462–464

    Article  CAS  Google Scholar 

  8. Zhou L, ZhangBao J, Li H, Li X, Huang Y, Wang M, Zhao C, Lu J, Lu C, Li Y, Quan C (2017) Cerebral cortical encephalitis followed by recurrent CNS demyelination in a patient with concomitant anti-MOG and anti-NMDA receptor antibodies. Mult Scler Relat Disord 18:90–92

    Article  Google Scholar 

  9. Dalmau J, Gleichman AJ, Hughes EG, Rossi JE, Peng X, Lai M, Dessain SK, Rosenfeld MR, Balice-Gordon R, Lynch DR (2008) Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol 7:1091–1098

    Article  CAS  Google Scholar 

Download references

Acknowledgments

The authors thank Professor Josep Dalmau in Service of Neurology, IDIBAPS Hospital Clínic, University of Barcelona, Casanova (Spain), for examining antibodies against cell-surface antigens and critical comments on this study. We also thank Dr. Keiko Tanaka in Department of Animal Model Development, Brain Research Institute, Niigata University (Japan), for examining anti-NMDAR-antibodies.

Funding

This work was supported in part by the Japan Epilepsy Research Foundation (JERF TENKAN 17002, TI).

Author information

Authors and Affiliations

Authors

Contributions

EA and AM equally contributed to drafting and revising the manuscript, data collection, study concept, and interpretation of data. NK and TI contributed to data collection, interpretation of data, and revising the manuscript. All authors give final approval of the version to be published.

Corresponding author

Correspondence to Eiichiro Amano.

Ethics declarations

Conflict of interest

EA, AM, and NK do not have anything to disclose regarding conflicts of interest or commercial relationships including grants, honoraria, speaker’s lists, significant ownership, or financial support from pharmaceutical or other companies. TI received a grant from The Japan Epilepsy Research Foundation and research support from Astellas Pharma Inc.

Ethical approval

Informed consent was obtained from the patient described in this article.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

ESM 1

(DOCX 42 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Amano, E., Machida, A., Kanazawa, N. et al. Cerebrospinal fluid MOG-antibodies in anti-NMDA receptor encephalitis with leptomeningeal enhancement. Neurol Sci 41, 2635–2638 (2020). https://doi.org/10.1007/s10072-020-04343-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-020-04343-3

Navigation